Self-care Behaviors of Type 2 Diabetes Mellitus Patients
The goal of this observational study is to explore the experience of the chronic disease, with a particular focus on self-care, in adults with type 2 diabetes mellitus. The main questions it aims to answer are: * what is the association between self-care and glycated hemoglobin over time? * what are participants' clinical and sociodemographic characteristics influencing self-care behaviors? Participants' socio-demographic and clinical data will be collected by medical records and, at the beginning or at the end…
Conditions studied
Type 2 Diabetes
About this study
The goal of this observational study is to explore the experience of the chronic disease, with a particular focus on self-care, in adults with type 2 diabetes mellitus. The main questions it aims to answer are: * what is the association between self-care and glycated hemoglobin over time? * what are participants' clinical and sociodemographic characteristics influencing self-care behaviors? Participants' socio-demographic and clinical data will be collected by medical records and, at the beginning or at the end of the clinical standard outpatient visit, they will be asked to complete study questionnaires. The results of this study could be helpful in providing quality assistance, improving resource consumption, and reducing the onset of complications.
Primary outcomes
- Self-care in diabetes [1] (The SCODI will be administered at the following time point: T0 - Baseline.)
- Self-care in diabetes [2] (The SCODI will be administered by telephone at the following time point: T0.5 - Month 6 ± 28 days)
- Self-care in diabetes [3] (The SCODI will be administered by telephone at the following time point: T1 - Month 12 ± 28 days.)
- Self-care in diabetes [4] (The SCODI will be administered by telephone at the following time point: T1.5 - Month 18 ± 28 days.)
- Self-care in diabetes [5] (The SCODI will be administered by telephone at the following time point: T2 - Month 24 ± 28 days.)
Eligibility information
Study locations
- IRCCS Policlinico San Donato, San Donato Milanese, Milan 20097 Italy
- Fondazione IRCCS San Gerardo dei Tintori, Monza, Monza Brianza 20900 Italy
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.